Chronic obstructive pulmonary disease: new opportunities for drug development

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.10, 1998-10, pp. : 415-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities

By Hersh Craig P

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 237-247

Future Medicine

Access to resources Recommend Favorite

Dysfunction of Pulmonary Vascular Endothelium in Chronic Obstructive Pulmonary Disease: Basic Considerations for Future Drug Development

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 661-667

Bentham Science Publishers

Access to resources Recommend Favorite

New therapies for chronic obstructive pulmonary disease

By Krishna Ganesh Sankaranarayanan Viji Chitkara Rajinder K

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 255-267

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease: Summary and Table

Pharmaceutical Medicine, Vol. 25, Iss. 4, 2011-08 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite